We hypothesized that @entity308 might represent a barrier to reach an ideal cardiovascular health (CVH) as estimated by the 7-item tool proposed by the American Heart Association. Between 2008 and 2012, 9,417 subjects 50-75 years of age were examined in a large health center and enrolled in the Paris Prospective Study III (PPS3). @entity1 with 0-2, 3-4 and 5-7 health metrics at the ideal level were categorized as having poor, intermediate and ideal CVH, respectively. @entity1 with a score >= 7 on the 13-item Questionnaire of Depression 2nd version, Abridged or who were on antidepressants were referred as having high level of @entity308 (HLDS). The mean age of the 9417 study @entity1 was 59.57 (SD 6.28) years and 61.16% were males. A total of 9.55% had HLDS. Poor, intermediate and ideal CVH was present in 40.38%, 49.52% and 10.10% of the @entity1 . In multivariate polytomous logistic regression analysis, HLDS was inversely associated with ideal CVH (odds ratio   =   0.70; 95% CI: 0.55;0.90). This was driven by an association with the behavioural component of the CVH. @entity1 with HLDS had a substantial reduced chance of reaching an ideal CVH.

High level of XXXX as a barrier to reach an ideal cardiovascular health. The Paris Prospective Study III.

@entity1 :: ('9606', 'Species') :: ['participants', 'Participants'] @entity308 :: ('MESH:D003866', 'Disease') :: ['depressive symptoms', 'depression']
@entity308 :: (MESH:D003866,Disease) :: ['depressive symptoms']
